| | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
---|
|
|
| | IP | | | Prolutex 25 mg | | PR | PR | k.A. | | Injection solution: Progesteronum 25mg / 1.112ml | IBSA Institut Biochimique SA | A | FB | | G |  |
| | IP | | | Prolutex 25 mg | 7 | PR | PR | k.A. | | Injection solution: Progesteronum 25mg / 1.112ml | IBSA Institut Biochimique SA | A | FB | | G |  |
| | IP | | | Prolutex 25 mg | 14 | PR | PR | k.A. | | Injection solution: Progesteronum 25mg / 1.112ml | IBSA Institut Biochimique SA | A | FB | | G |  |
| | IP | CI | | Moxifloxacine Rivopharm | 5 | PR | PR | k.A. | | compresse rivestite con film: Moxifloxacinum 400 mg | Rivopharm SA | A | FB | | G |  |
| | IP | CI | | Moxifloxacine Rivopharm | 7 | PR | PR | k.A. | | compresse rivestite con film: Moxifloxacinum 400 mg | Rivopharm SA | A | FB | | G |  |
| | IP | CI | | Moxifloxacine Rivopharm | 10 | PR | PR | k.A. | | compresse rivestite con film: Moxifloxacinum 400 mg | Rivopharm SA | A | FB | | G |  |
L | | IP | CI | | Imnovid 1 mg | 21 Capsule(s) | 7814.18 | 8226.20 | 20 % | | Capsules: Pomalidomidum 1 mg | Bristol-Myers Squibb SA | A / SL / SO | FB | | G |  |
L | | IP | CI | | Imnovid 2 mg | 21 Capsule(s) | 7916.10 | 8333.25 | 20 % | | Capsules: Pomalidomidum 2 mg | Bristol-Myers Squibb SA | A / SL / SO | FB | | G |  |
L | | IP | CI | | Imnovid 3 mg | 21 Capsule(s) | 8018.03 | 8440.35 | 20 % | | Capsules: Pomalidomidum 3 mg | Bristol-Myers Squibb SA | A / SL / SO | FB | | G |  |
L | | IP | CI | | Imnovid 4 mg | 21 Capsule(s) | 8086.21 | 8512.00 | 20 % | | Capsules: Pomalidomidum 4 mg | Bristol-Myers Squibb SA | A / SL / SO | FB | | G |  |
| | IP | CI | | Letrozol Labatec 2.5 mg | 30 Tablet(s) | 54.88 | 76.00 | 10 % | | Coated tablets: Letrozolum 2.5 mg | Labatec Pharma SA | B / SL / SG | FB | | G |  |
| | IP | CI | | Letrozol Labatec 2.5 mg | 100 Tablet(s) | 182.09 | 214.15 | 10 % | | Coated tablets: Letrozolum 2.5 mg | Labatec Pharma SA | B / SL / SG | FB | | G |  |
| | IP | CI | | Moxifloxacin Sandoz 400 | 5 Tablet(s) | 15.53 | 33.30 | 10 % | | Coated tablets: Moxifloxacinum 400 mg | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | IP | CI | | Moxifloxacin Sandoz 400 | 7 Tablet(s) | 21.75 | 40.05 | 10 % | | Coated tablets: Moxifloxacinum 400 mg | Sandoz Pharmaceuticals AG | ● A / SL / SG | FB | | G |  |
| | IP | CI | | Moxifloxacin Sandoz 400 | 10 Tablet(s) | 27.38 | 46.20 | 10 % | | Coated tablets: Moxifloxacinum 400 mg | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | IP | CI | | Tramadol plus Spirig HC | 10 Tablet(s) | 1.45 | 10.80 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | A / SL / SG | FB | | G |  |
| | IP | CI | | Tramadol plus Spirig HC | 20 Tablet(s) | 2.64 | 12.10 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | A / SL / SG | FB | | G |  |
| | IP | CI | | Tramadol plus Spirig HC | 60 Tablet(s) | 7.92 | 17.85 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | ● A / SL / SG | FB | | G |  |
| | IP | CI | | Tramadol plus Spirig HC | 100 Tablet(s) | 11.61 | 29.05 | 10 % | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | A / SL / SG | FB | | G |  |
| | IP | CI | | Voriconazol Sandoz 50 mg | 56 Tablet(s) | 445.05 | 500.45 | 10 % | | Coated tablets: Voriconazolum 50 mg | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | IP | CI | | Voriconazol Sandoz 200 mg | 28 Tablet(s) | 890.10 | 984.45 | 10 % | | Coated tablets: Voriconazolum 200 mg | Sandoz Pharmaceuticals AG | A / SL / SG | FB | | G |  |
| | IP | CI | | Voriconazol-Mepha 50mg | 56 Tablet(s) | 445.05 | 500.45 | 10 % | | Coated tablets: Voriconazolum 50 mg | Mepha Pharma AG | A / SL / SG | FB | | G |  |
| | IP | CI | | Voriconazol-Mepha 200mg | 28 Tablet(s) | 890.10 | 984.45 | 10 % | | Coated tablets: Voriconazolum 200 mg | Mepha Pharma AG | A / SL / SG | FB | | G |  |
| | IP | CI | | Enalapril-Mepha 5 mg | 30 Tablet(s) | 2.69 | 12.15 | 10 % | | Tablets: Enalaprili Maleas 5 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Enalapril-Mepha 10 mg | 28 Tablet(s) | 4.36 | 14.00 | 10 % | | Tablets: Enalaprili Maleas 10 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Enalapril-Mepha 10 mg | 98 Tablet(s) | 15.21 | 32.95 | 10 % | | Tablets: Enalaprili Maleas 10 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Enalapril-Mepha 20 mg | 28 Tablet(s) | 8.10 | 25.25 | 10 % | | Tablets: Enalaprili Maleas 20 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Enalapril-Mepha 20 mg | 98 Tablet(s) | 25.14 | 43.75 | 10 % | | Tablets: Enalaprili Maleas 20 mg | Mepha Pharma AG | B / SL / SG | FB | | G |  |
| | IP | CI | | Oxynorm 5 mg | 28 Tablet(s) | 8.24 | 25.40 | 10 % | | Melting tablets: Oxycodoni Hydrochloridum 5 mg | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ / SL | FB | | G |  |
| | IP | CI | | Oxynorm 5 mg | 56 Tablet(s) | 14.50 | 32.20 | 10 % | | Melting tablets: Oxycodoni Hydrochloridum 5 mg | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ / SL | FB | | G |  |
| | IP | CI | | Oxynorm 10 mg | 28 Tablet(s) | 13.52 | 31.10 | 10 % | | Melting tablets: Oxycodoni Hydrochloridum 10 mg | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | A+ / SL | FB | | G |  |
| | IP | CI | | Oxynorm 10 mg | 56 Tablet(s) | 23.78 | 42.30 | 10 % | | Melting tablets: Oxycodoni Hydrochloridum 10 mg | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | ● A+ / SL | FB | | G |  |
L | | IP | | | Gazyvaro 1000 mg/40 ml | Durchstechflasche(n) | 3045.01 | 3328.05 | 10 % | | Concentrate for infusion: Obinutuzumabum 1000mg / 40ml | Roche Pharma (Schweiz) AG | A / SL | FB | | G |  |
| | | | PhCM | Floramed Beruhigungstee | 20 1 Sachet(s) à 1.3 g | PR | PR | k.A. | | Chopped herbs: 4 Active Agents | Morga AG | E | FB | | G |  |
| | | | PhCM | Floramed Blasentee | 20 1 Sachet(s) à 1.5 g | PR | PR | k.A. | | Chopped herbs: 5 Active Agents | Morga AG | E | FB | | G |  |
| | | | PhCM | Floramed Hustentee | 20 1 Sachet(s) à 1.2 g | PR | PR | k.A. | | Chopped herbs: 6 Active Agents | Morga AG | E | FB | | G |  |
| | | | PhCM | Floramed Orangenblütentee | 20 1 Sachet(s) à 1.2 g | PR | PR | k.A. | | | Morga AG | E | FB | | G |  |
| | IP | CI | | Moxifloxacin Sandoz 400 | 5 Tablet(s) | PR | PR | k.A. | | Coated tablets: Moxifloxacinum 400 mg | Sandoz Pharmaceuticals AG | A | FB | | G |  |
| | IP | CI | | Moxifloxacin Sandoz 400 | 7 Tablet(s) | PR | PR | k.A. | | Coated tablets: Moxifloxacinum 400 mg | Sandoz Pharmaceuticals AG | A | FB | | G |  |
| | IP | CI | | Moxifloxacin Sandoz 400 | 10 Tablet(s) | PR | PR | k.A. | | Coated tablets: Moxifloxacinum 400 mg | Sandoz Pharmaceuticals AG | A | FB | | G |  |
| | IP | CI | | Sue 20 | 21 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / LPPV | FB | | G |  |
| | IP | CI | | Sue 20 | 3 x 21 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / LPPV | FB | | G |  |
| | IP | CI | | Sue 20 | 6 x 21 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / LPPV | FB | | G |  |
| | IP | CI | | Sue 30 | 21 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / LPPV | FB | | G |  |
| | IP | CI | | Sue 30 | 3 x 21 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / LPPV | FB | | G |  |
| | IP | CI | | Sue 30 | 6 x 21 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / LPPV | FB | | G |  |
| | IP | CI | | Suzanne | 28 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / LPPV | FB | | G |  |
| | IP | CI | | Suzanne | 3 x 28 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / LPPV | FB | | G |  |
| | IP | CI | | Suzanne | 6 x 28 Tablet(s) | PR | PR | k.A. | | Coated tablets: 2 Active Agents | Spirig HealthCare AG | B / LPPV | FB | | G |  |
| | IP | CI | | Imnovid 1 mg | 14 | PR | PR | k.A. | | Capsules: Pomalidomidum 1 mg | Bristol-Myers Squibb SA | A | FB | | G |  |
| | IP | CI | | Imnovid 2 mg | 14 | PR | PR | k.A. | | Capsules: Pomalidomidum 2 mg | Bristol-Myers Squibb SA | A | FB | | G |  |
| | IP | CI | | Imnovid 3 mg | 14 | PR | PR | k.A. | | Capsules: Pomalidomidum 3 mg | Bristol-Myers Squibb SA | A | FB | | G |  |
| | IP | CI | | Imnovid 4 mg | 14 | PR | PR | k.A. | | Capsules: Pomalidomidum 4 mg | Bristol-Myers Squibb SA | A | FB | | G |  |
| | | | PhCM | Floramed Erkältungstee | 20 1 Sachet(s) à 1.5 g | PR | PR | k.A. | | Arzneitee: 4 Active Agents | Morga AG | E | FB | | G |  |
| | | | PhCM | Floramed Leber-Galle-Tee | 20 1 Sachet(s) à 1.5 g | PR | PR | k.A. | | Arzneitee: 5 Active Agents | Morga AG | E | FB | | G |  |
| | | | PhCM | Floramed Magentee | 20 1 Sachet(s) à 1 g | PR | PR | k.A. | | Arzneitee: 7 Active Agents | Morga AG | E | FB | | G |  |
| | IP | CI | | Arilin 1000 mg | suppositories | PR | PR | k.A. | | Vaginalzäpfchen: Metronidazolum 1000 mg | Alcina AG | B | FB | | G |  |
| | IP | CI | | Arilin 1000 mg | 2 suppositories | PR | PR | k.A. | | Vaginalzäpfchen: Metronidazolum 1000 mg | Alcina AG | B | FB | | G |  |
L | | IP | | | Humira | 2 x 0.8 ml | 1138.23 | 1309.85 | 10 % | | Adalimumabum 40 mg | AbbVie AG | B / SL | FB | | G |  |
| | IP | CI | | Drospibel 20 | 21 Tablet(s) | PR | PR | k.A. | | compresse rivestite con film: 2 Active Agents | Effik SA | B | FB | | G |  |
| | IP | CI | | Drospibel 20 | 3 x 21 Tablet(s) | PR | PR | k.A. | | compresse rivestite con film: 2 Active Agents | Effik SA | B | FB | | G |  |
| | IP | CI | | Drospibel 20 | 6 x 21 Tablet(s) | PR | PR | k.A. | | compresse rivestite con film: 2 Active Agents | Effik SA | B | FB | | G |  |
| | IP | CI | | Drospibel 30 | 21 Tablet(s) | PR | PR | k.A. | | compresse rivestite con film: 2 Active Agents | Effik SA | B | FB | | G |  |
| | IP | CI | | Drospibel 30 | 3 x 21 Tablet(s) | PR | PR | k.A. | | compresse rivestite con film: 2 Active Agents | Effik SA | B | FB | | G |  |
| | IP | CI | | Drospibel 30 | 6 x 21 Tablet(s) | PR | PR | k.A. | | compresse rivestite con film: 2 Active Agents | Effik SA | B | FB | | G |  |